Literature DB >> 9593678

Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4.

Z S Ji1, R E Pitas, R W Mahley.   

Abstract

Isoform-specific effects of apolipoprotein E (apoE) on neurite outgrowth and the cytoskeleton are associated with higher intracellular levels of apoE3 than apoE4 in cultured neurons. The current studies, designed to determine the mechanism for the differential intracellular accumulation or retention of apoE, demonstrate that apoE3- and apoE4-containing beta-very low density lipoproteins (beta-VLDL) possess similar cell binding and internalization and delivery of cholesterol to the cells. However, as assessed by immunocytochemistry, analysis of extracted cellular proteins, or quantitation of 125I-apoE-enriched beta-VLDL, there was a 2-3-fold greater accumulation of apoE3 than apoE4 in Neuro-2a cells, fibroblasts, and hepatocytes (HepG2) after 1-2 h, and this differential was maintained for up to 48 h. ApoE2 also accumulated in Neuro-2a cells to a greater extent than apoE4. The differential effect was mediated by the apoE-enriched beta-VLDL and not by free apoE. Neither the low density lipoprotein receptor nor the low density lipoprotein receptor-related protein was responsible for the differential accumulation of apoE3 and apoE4, since cells deficient in either or both of these receptors also displayed the differential accumulation. The effect appears to be mediated primarily by cell surface heparan sulfate proteoglycans (HSPG). The retention of both apoE3 and apoE4 was markedly reduced, and the differential accumulation of apoE3 and apoE4 was eliminated both in mutant Chinese hamster ovary cells that did not express HSPG and in HSPG-expressing cells treated with heparinase. The data suggest that cell surface HSPG directly mediate the uptake of apoE-containing lipoproteins, that the differential accumulation/retention of apoE by cells is mediated via HSPG, and that there is a differential intracellular handling of the specific apoE isoforms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593678     DOI: 10.1074/jbc.273.22.13452

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.

Authors:  M Buttini; M Orth; S Bellosta; H Akeefe; R E Pitas; T Wyss-Coray; L Mucke; R W Mahley
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

2.  Scavenging new insights into atherogenesis.

Authors:  M P de Winther; M H Hofker
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

3.  Depressed neurofilament expression associates with apolipoprotein E3/E4 genotype in maturing human fetal neurons exposed to HIV-1.

Authors:  Ricardo Martinez; Wu Chunjing; Rebeca Geffin; Micheline McCarthy
Journal:  J Neurovirol       Date:  2012-08       Impact factor: 2.643

4.  Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake.

Authors:  Takahisa Kanekiyo; Juan Zhang; Qiang Liu; Chia-Chen Liu; Lijuan Zhang; Guojun Bu
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

5.  Apo E structure determines VLDL clearance and atherosclerosis risk in mice.

Authors:  C Knouff; M E Hinsdale; H Mezdour; M K Altenburg; M Watanabe; S H Quarfordt; P M Sullivan; N Maeda
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

6.  An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation.

Authors:  Christine M Bojanowski; Defen Shen; Emily Y Chew; Baitang Ning; Karl G Csaky; W Richard Green; Chi-Chao Chan; Jingsheng Tuo
Journal:  Environ Mol Mutagen       Date:  2006-10       Impact factor: 3.216

7.  A test of the cytosolic apolipoprotein E hypothesis fails to detect the escape of apolipoprotein E from the endocytic pathway into the cytosol and shows that direct expression of apolipoprotein E in the cytosol is cytotoxic.

Authors:  R B DeMattos; F E Thorngate; D L Williams
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

8.  Expression and regulation of apolipoprotein E receptors in the cells of the central nervous system in culture: A review.

Authors:  Q W Fan; I Iosbe; H Asou; K Yanagisawa; M Michikawa
Journal:  J Am Aging Assoc       Date:  2001-01

9.  Role of the N- and C-terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: a surface plasmon resonance study.

Authors:  Yuko Yamauchi; Noriko Deguchi; Chika Takagi; Masafumi Tanaka; Padmaja Dhanasekaran; Minoru Nakano; Tetsurou Handa; Michael C Phillips; Sissel Lund-Katz; Hiroyuki Saito
Journal:  Biochemistry       Date:  2008-06-24       Impact factor: 3.162

Review 10.  Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review.

Authors:  Inga Kuhlmann; Anne Marie Minihane; Patricia Huebbe; Almut Nebel; Gerald Rimbach
Journal:  Lipids Health Dis       Date:  2010-01-28       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.